Recent investigations have revealed that the alkaline phosphatase-to-albumin ratio (APAR) is an essential biomarker of prognosis in several diseases, including cancer, coronary heart disease, and acute renal failure12–14. This evidence concerns the gene ALB and coronary artery disorder.